Proposed Data Collections Submitted for Public Comment and Recommendations, 19015-19016 [2012-7534]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Requirements and
Registration for Beat Down Blood
Pressure Challenge
Office of the National
Coordinator for Health Information
Technology, Department of Health and
Human Services (HHS).
ACTION: Federal Register Notice;
Correction.
AGENCY:
On March 22, 2012 the Office
of the National Coordinator for Health
Information Technology, located within
the Department of Health and Human
Services (HHS) published a notice in the
Federal Register (77 FR 17060)
announcing requirements and
registration for a Beat Down Blood
Pressure Video Challenge. This
challenge will not be open to the public
until Wednesday, March 28th. On 3/28,
we encourage you to visit https://
BloodPressure.Challenge.gov for a
complete set of rules and requirements
for this contest.
FOR FURTHER INFORMATION CONTACT: For
questions concerning this notice please
contact: Erin Poetter, MPH, Office of the
National Coordinator for Health
Information Technology, HHS, erin.
poetter@hhs.gov or 202–205–3310.
SUMMARY:
Dated: March 21, 2012.
Erin Poetter,
Consumer e-Health Policy Analyst ONC,
Department of Health and Human Services.
[FR Doc. 2012–7485 Filed 3–28–12; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). Notice of
these meetings is given under the
Federal Advisory Committee Act
(5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). The Advisory Council on
Alzheimer’s Research, Care, and
Services provides advice on how to
prevent or reduce the burden of
Alzheimer’s disease and related
dementias on people with the disease
and their caregivers. The Advisory
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:14 Mar 28, 2012
Jkt 226001
Council will discuss the Draft National
Plan to Address Alzheimer’s Disease,
and, as appropriate, make
recommendations to the Secretary of
HHS.
Meeting Date: April 17, 2012 from
9 a.m. to 4:15 p.m. EDT.
ADDRESSES: The meeting will be held at
the U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 800, Washington,
DC 20201.
Comments: Time is allocated on the
agenda to hear public comments. In lieu
of oral comments, formal written
comments may be submitted for the
record to Helen Lamont, OASPE, 200
Independence Avenue SW., Room 424E,
Washington, DC 20201. Comments may
also be sent to napa@hhs.gov. Those
submitting written comments should
identify themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont (202) 690–7996,
helen.lamont@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put (April 17
meeting attendance) in the Subject line
by Wednesday, April 11, 2012, so that
their names may be put on a list of
expected attendees and forwarded to the
security officers at the Department of
Health and Human Services. Any
interested member of the public who is
a non-U.S. citizen should include this
information at the time of registration to
ensure that the appropriate security
procedure to gain entry to the building
is carried out. Although the meeting is
open to the public, procedures
governing security and the entrance to
Federal buildings may change without
notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Topics of
the Meeting: The Advisory Council will
discuss the Draft National Plan to
Address Alzheimer’s Disease.
Procedure and Agenda: This meeting
is open to the public. The Advisory
Council will discuss the Draft National
Plan to Address Alzheimer’s Disease,
and, as appropriate, make
recommendations to the Secretary of
HHS.
Proposed Project
SUPPLEMENTARY INFORMATION:
Office of the Assistant Secretary for
Planning and Evaluation; Meeting of
the Advisory Council on Alzheimer’s
Research, Care, and Services
19015
Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Sherry Glied,
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2012–7482 Filed 3–28–12; 8:45 am]
BILLING CODE P
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
[60Day–12–12GO]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane, at
CDC 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Colorectal Cancer Control Program
Indirect/Non-Medical Cost Study—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal Cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States, following lung
cancer. Based on scientific evidence
which indicates that regular screening is
effective in reducing CRC incidence and
mortality, regular CRC screening is now
recommended for average-risk persons.
Screening tests that may be used alone
or in combination include fecal occult
blood testing (FOBT), fecal
immunochemical testing (FIT), flexible
sigmoidoscopy, and/or colonoscopy.
E:\FR\FM\29MRN1.SGM
29MRN1
19016
Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices
While screening rates have increased
over the past decade, screening
prevalence is still lower than desirable,
particularly among individuals with low
socioeconomic status. The indirect and
non-medical costs associated with CRC
screening, such as travel costs, may act
as barriers to screening. Understanding
these costs may provide insights that
can be used to reduce such barriers and
increase participation.
In 2005, CDC established a four-year
demonstration program at five sites to
screen low-income individuals aged 50–
64 years who had no health insurance
or inadequate health insurance for CRC.
In 2009, by applying lessons learned
from the demonstration program, CDC
designed and initiated the larger
population-based Colorectal Cancer
Control Program (CRCCP) at 29 sites.
The goals of the expanded program are
to reduce health disparities in CRC
screening, incidence and mortality by
promoting CRC screening for the eligible
population and providing CRC
screening to low-income adults over 50
years of age who have no health
insurance or inadequate health
insurance for CRC screening.
To date there has been no
comprehensive assessment of all the
costs associated with CRC screening,
especially indirect and non-medical
costs, incurred by the low-income
population served by the CRCCP. CDC
proposes to address this gap by
collecting information from a subset of
patients enrolled in the program. Those
who undergo screening by FIT or
colonoscopy will be asked to complete
a specialized questionnaire about the
time and personal expense associated
with their screening. Patients who
undergo fecal immunochemical testing
will be asked to complete the FIT
questionnaire, which is estimated to
take about 10 minutes. Patients who
undergo colonoscopy will be asked to
complete the Colonoscopy
questionnaire, which includes
additional questions about the
preparation and recovery associated
with this procedure. The estimated
burden per response for the
Colonoscopy questionnaire is 25
minutes. Demographic information will
be collected from all patients who
participate in the study. Participation in
the study is voluntary, but patients will
be offered an incentive in the form of a
gift card.
CDC plans to conduct the information
collection in partnership with providers
in five states (Alabama, Arizona,
Colorado, New York, and Pennsylvania).
Each provider site will administer the
survey until it reaches a target number
of responses. Targets for each site range
between 75 and 150 completed
questionnaires, depending on the
volume of patients screened. Each
participating provider will make patient
navigators available to assist patients
with coordinating the screening process
and completing the questionnaires.
Providers will be reimbursed for patient
navigator time and administrative
expense associated with data collection.
Across the five participating sites, the
estimated cost of this data collection is
approximately $50,000.
This information collection will be
used to produce estimates of the
personal costs incurred by patients who
undergo CRC screening by FIT or
colonoscopy, and to improve
understanding of these costs as potential
barriers to participation. Study findings
will be disseminated through reports,
presentations, and publications. Results
will also be used by participating sites,
CDC, and other federal agencies to
improve delivery of CRC screening
services and to increase screening rates
among low-income adults over 50 years
of age who have no health insurance or
inadequate health insurance for CRC
screening.
OMB approval is requested for one
year. Each respondent will have the
option of completing a hardcopy
questionnaire or an on-line
questionnaire. No identifiable
information will be collected by CDC or
CDC’s data collection contractor. There
are no costs to respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondent
Form type
Patients Served by the Colorectal
Cancer Control Program.
FIT questionnaire .............................
300
1
10/60
50
Colonoscopy questionnaire ..............
315
1
25/60
131
...........................................................
........................
........................
........................
181
Total ...........................................
Dated: March 23, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science (OADS),
Office of the Director, Centers for Disease
Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–12–0040]
[FR Doc. 2012–7534 Filed 3–28–12; 8:45 am]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
VerDate Mar<15>2010
17:14 Mar 28, 2012
Jkt 226001
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, at CDC
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 77, Number 61 (Thursday, March 29, 2012)]
[Notices]
[Pages 19015-19016]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-12-12GO]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly S. Lane, at CDC 1600 Clifton Road, MS-
D74, Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Colorectal Cancer Control Program Indirect/Non-Medical Cost Study--
New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal Cancer (CRC) is the second leading cause of cancer-
related deaths in the United States, following lung cancer. Based on
scientific evidence which indicates that regular screening is effective
in reducing CRC incidence and mortality, regular CRC screening is now
recommended for average-risk persons. Screening tests that may be used
alone or in combination include fecal occult blood testing (FOBT),
fecal immunochemical testing (FIT), flexible sigmoidoscopy, and/or
colonoscopy.
[[Page 19016]]
While screening rates have increased over the past decade,
screening prevalence is still lower than desirable, particularly among
individuals with low socioeconomic status. The indirect and non-medical
costs associated with CRC screening, such as travel costs, may act as
barriers to screening. Understanding these costs may provide insights
that can be used to reduce such barriers and increase participation.
In 2005, CDC established a four-year demonstration program at five
sites to screen low-income individuals aged 50-64 years who had no
health insurance or inadequate health insurance for CRC. In 2009, by
applying lessons learned from the demonstration program, CDC designed
and initiated the larger population-based Colorectal Cancer Control
Program (CRCCP) at 29 sites. The goals of the expanded program are to
reduce health disparities in CRC screening, incidence and mortality by
promoting CRC screening for the eligible population and providing CRC
screening to low-income adults over 50 years of age who have no health
insurance or inadequate health insurance for CRC screening.
To date there has been no comprehensive assessment of all the costs
associated with CRC screening, especially indirect and non-medical
costs, incurred by the low-income population served by the CRCCP. CDC
proposes to address this gap by collecting information from a subset of
patients enrolled in the program. Those who undergo screening by FIT or
colonoscopy will be asked to complete a specialized questionnaire about
the time and personal expense associated with their screening. Patients
who undergo fecal immunochemical testing will be asked to complete the
FIT questionnaire, which is estimated to take about 10 minutes.
Patients who undergo colonoscopy will be asked to complete the
Colonoscopy questionnaire, which includes additional questions about
the preparation and recovery associated with this procedure. The
estimated burden per response for the Colonoscopy questionnaire is 25
minutes. Demographic information will be collected from all patients
who participate in the study. Participation in the study is voluntary,
but patients will be offered an incentive in the form of a gift card.
CDC plans to conduct the information collection in partnership with
providers in five states (Alabama, Arizona, Colorado, New York, and
Pennsylvania). Each provider site will administer the survey until it
reaches a target number of responses. Targets for each site range
between 75 and 150 completed questionnaires, depending on the volume of
patients screened. Each participating provider will make patient
navigators available to assist patients with coordinating the screening
process and completing the questionnaires. Providers will be reimbursed
for patient navigator time and administrative expense associated with
data collection. Across the five participating sites, the estimated
cost of this data collection is approximately $50,000.
This information collection will be used to produce estimates of
the personal costs incurred by patients who undergo CRC screening by
FIT or colonoscopy, and to improve understanding of these costs as
potential barriers to participation. Study findings will be
disseminated through reports, presentations, and publications. Results
will also be used by participating sites, CDC, and other federal
agencies to improve delivery of CRC screening services and to increase
screening rates among low-income adults over 50 years of age who have
no health insurance or inadequate health insurance for CRC screening.
OMB approval is requested for one year. Each respondent will have
the option of completing a hardcopy questionnaire or an on-line
questionnaire. No identifiable information will be collected by CDC or
CDC's data collection contractor. There are no costs to respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form type respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Patients Served by the FIT 300 1 10/60 50
Colorectal Cancer Control questionnaire.
Program.
Colonoscopy 315 1 25/60 131
questionnaire.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 181
----------------------------------------------------------------------------------------------------------------
Dated: March 23, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-7534 Filed 3-28-12; 8:45 am]
BILLING CODE 4163-18-P
